Battley, Jodie E <br/><br/>
Treatment of BRAF inhibitor-induced hyperkeratosis.  [electronic resource] 

 -  Acta oncologica (Stockholm, Sweden)  May 2013 
 - 874-7 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>1651-226X 
<br/><br/><label>Standard No.: </label>10.3109/0284186X.2012.716165  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Inflammatory Agents--therapeutic use<br/>Antineoplastic Agents--adverse effects<br/>Clobetasol--therapeutic use<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Imidazoles--adverse effects<br/>Keratoderma, Palmoplantar--chemically induced<br/>Male<br/>Melanoma--drug therapy<br/>Oximes--adverse effects<br/>Protein Kinase Inhibitors--adverse effects<br/>Proto-Oncogene Proteins B-raf--antagonists & inhibitors